Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Sale of 16,667 BEAM shares, $429.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 16,667 | $429.0K |
| Jul 2, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 373 | $13.0K |
| Apr 6, 2026 | Beam Therapeutics Inc. (BEAM) | Sale | 6,700 | $164.7K |
| Apr 2, 2026 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 31,750 | n/a |
| Feb 2, 2026 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 88,500 | n/a |
| Jan 5, 2026 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 12,500 | n/a |
| Jul 3, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 374 | $6.3K |
| Apr 4, 2025 | Beam Therapeutics Inc. (BEAM) | Sale | 9,566 | $175.5K |
| Apr 2, 2025 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 27,500 | n/a |
| Feb 3, 2025 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 55,000 | n/a |